Metropolis Healthcare Limited has informed the Exchange about the declaration of 2nd Interim Dividend and Record date.
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare declared a 2nd Interim Dividend of INR 1 per equity share (face value INR 2) for FY 2025-26, with May 19, 2026 as the record date. The full-year FY26 standalone revenue grew 12.3% to INR 13,655 lakhs, while consolidated revenue surged 23.6% to INR 16,458 lakhs, driven by acquisitions (DAPIC, Scientific Metropolis, Dr. RS Patil's lab). Standalone PAT rose 26.2% to INR 1,575 lakhs and consolidated PAT jumped 31.4% to INR 1,912 lakhs. Exceptional items of INR 795.67 lakhs (standalone) and INR 898.96 lakhs (consolidated) represent non-recurring statutory impact of new Labour Codes. Auditors B S R & Co. LLP are retiring after completing their second term; Deloitte Haskins & Sells LLP is recommended as successor. The company completed a 3:1 bonus share issuance during the year.
Strong financial performance with PAT growth exceeding 25% on consolidated basis; dividend payout is modest at INR 1 per share (INR 20.73 crores total) signaling confidence in cash generation. Auditor change at AGM is routine succession, not a concern.